UPDATE: Telsey Downgrades Bed Bath & Beyond (BBBY) to Underperform

Bed Bath & Beyond (BBBY) PT Lowered to $12 at UBS

UBS analyst Michael Lasser lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $12.00 (from $13.00) while maintaining a Sell rating.... More

UPDATE: Bed Bath & Beyond (BBBY) Has 60% Downside, PT Lowered to $7 at Morgan Stanley

(Updated - April 14, 2022 7:45 AM EDT)

Morgan Stanley analyst Simeon Gutman lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $7.00 (from $8.00) after the lack of inventory drove a big Q4'21 sales/earnings miss. However, the bigger issue is management's ability to... More

Bed Bath & Beyond (BBBY) Stock is Down After Big EPS Miss, Analyst Sees No Positives

Shares of Bed Bath & Beyond (NASDAQ: BBBY) are down over 4% today after the company reported a worse-than-expected Q4 adjusted loss per share.

The retail store company reported a Q4 adjusted loss per share of 92c, compared to the expected EPS of 13c. Net sales came in at $2.05 billion, short of the consensus estimates of $2.08 billion.

Comparable sales were down 12% in the quarter, while analysts were looking for a... More

Pre-Open Stock Movers 04/13: (ATRS) (SRRA) (STAB) Higher; (NSTG) (LQDA) (BBBY) Lower (more...)

Pre-Open Stock Movers:

Antares Pharma, Inc. (NASDAQ: ATRS) 49% HIGHER; Halozyme Therapeutics, Inc. (NASDAQ: HALO) agreed to acquire the company for $5.60 per share in cash, or $960 million.

Sierra Oncology, Inc (Nasdaq: SRRA) 38% HIGHER;... More

Goldman Sachs on Bed Bath & Beyond (BBBY): 'sizable miss to our expectations', Says of Co Bonds 'We expect the market reaction to be quite negative'

Goldman Sachs analyst Kate McShane reiterated a Sell rating and $14.00 price target on Bed Bath & Beyond (NASDAQ: BBBY).

The analyst comments "BBBY reported 4Q21 adj. EPS of ($0.92), much below Consensus (Reuters) of $0.03, with a comp decline of 12%, vs GS/ Consensus estimates of -8%/-9%. The Bed, Bath & Beyond banner witnessed a comp decline of 15%, while there was growth of low single digits for the buybuy Baby banner compared to mid teen growth for the banner in 3Q21.... More

Bed Bath & Beyond (BBBY) Misses Q4 EPS by 95c

Bed Bath & Beyond (NASDAQ: BBBY) reported Q4 EPS of ($0.92), $0.95 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $2.05 billion versus the consensus estimate of $2.07 billion.

Fiscal 2022 Outlook Commentary:

At this time, the Company is providing the following... More

Stocks expected to have increasing option volume: BBBY FAST DAL FAST

Stocks expected to have increasing option volume: BBBY FAST DAL FAST

Bed Bath & Beyond (BBBY) April option implied volatility elevated into quarter results

Bed Bath & Beyond (NASDAQ: BBBY) April call option implied volatility is at 269, May is at 115; compared to its 52-week range of 57 to 194 into the expected release of quarter results before the bell on April 13.

Bed Bath & Beyond (BBBY) Stock: BofA Says 'Reality About to Hit Hard' for Reddit Investors, Analyst Sees 50% Downside Risk

Bank of America analyst Jason Haas has reiterated an Underperform rating on Bed Bath & Beyond (NASDAQ: BBBY) stock ahead of tomorrows earnings report.

Haas also reminded investors that BBBY stock is one of the top Underperform ideas for 2022 at Bank of America as the company continues to lose market share to rivals.

BBBYs 4Q comp guidance of down high single digits implies comps down roughly 10% on a 3-year basis vs. +23% 3-year home furnishings industry growth per the US Census. BBBY has been losing share for years as consumers have increasingly consolidated... More

Bed Bath & Beyond (BBBY) April 19 straddle bid into quarter results

Bed Bath & Beyond (NASDAQ: BBBY) April 19 straddle priced for a move of +/- 18% into the expected release of quarter results before the bell on April 13.